SAB Biotherapeutics, Inc.
SABS·NasdaqCM
2.8300−0.1500 (−5.03%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours2.8800+0.0500 (+1.77%)Oct 12, 7:32 PM EDT
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close2.9800
Open2.9700
Day range2.80002.9900
52-week range2.10005.1500
Off day high−5.35%
Off 52-week high−45.05%
Volume358.96K
Avg. volume (3M)503.34K
Market cap257.49M
EPS (TTM)-1.29
Forward P/E-2.97
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding90.99M
Short interest—
Earnings dateAug 6, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| SABS | ABUS | ZURA | SANA | CLYM | AGMB | |
|---|---|---|---|---|---|---|
| Market cap | 257.49M | 636.10M | 383.32M | 784.32M | 622.03M | 447.66M |
| P/E (TTM) | — | 5.3 | — | — | — | — |
| Forward P/E | -3.0 | -25.1 | -5.8 | -4.7 | -10.8 | -4.4 |
| Price/book | 1.1 | 3.2 | 1.9 | 5.1 | 2.6 | 3.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +29.00% | −3.04% | +3.63% | −35.79% | +450.00% | −37.95% |
| Today | −5.03% | −1.66% | 0.00% | −6.09% | −1.55% | +0.11% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SABS news ›No recent coverage in the 4Search index.
From articles in the 4Search news index.